CN106237384B - 复合梯度浓度生物活性因子组织支架、其制备方法及应用 - Google Patents
复合梯度浓度生物活性因子组织支架、其制备方法及应用 Download PDFInfo
- Publication number
- CN106237384B CN106237384B CN201510671803.4A CN201510671803A CN106237384B CN 106237384 B CN106237384 B CN 106237384B CN 201510671803 A CN201510671803 A CN 201510671803A CN 106237384 B CN106237384 B CN 106237384B
- Authority
- CN
- China
- Prior art keywords
- factor
- gradient
- collagen
- scaffold
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 230000008520 organization Effects 0.000 title abstract 2
- 238000000576 coating method Methods 0.000 claims abstract description 45
- 239000011248 coating agent Substances 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000007921 spray Substances 0.000 claims abstract description 17
- 210000000130 stem cell Anatomy 0.000 claims abstract description 16
- 238000007590 electrostatic spraying Methods 0.000 claims abstract description 9
- 102000008186 Collagen Human genes 0.000 claims description 70
- 108010035532 Collagen Proteins 0.000 claims description 70
- 229920001436 collagen Polymers 0.000 claims description 70
- 210000004027 cell Anatomy 0.000 claims description 36
- 238000004113 cell culture Methods 0.000 claims description 34
- 210000001178 neural stem cell Anatomy 0.000 claims description 34
- 239000000835 fiber Substances 0.000 claims description 30
- 239000002407 tissue scaffold Substances 0.000 claims description 28
- 239000011159 matrix material Substances 0.000 claims description 23
- 239000012528 membrane Substances 0.000 claims description 23
- 239000002131 composite material Substances 0.000 claims description 22
- 230000000975 bioactive effect Effects 0.000 claims description 20
- 230000004927 fusion Effects 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 230000009870 specific binding Effects 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 8
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 238000001523 electrospinning Methods 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 5
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 4
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 4
- 210000004748 cultured cell Anatomy 0.000 claims description 3
- 230000004071 biological effect Effects 0.000 claims 2
- 230000005012 migration Effects 0.000 abstract description 6
- 238000013508 migration Methods 0.000 abstract description 6
- 230000004069 differentiation Effects 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 238000009826 distribution Methods 0.000 description 37
- 240000000220 Panda oleosa Species 0.000 description 6
- 235000016496 Panda oleosa Nutrition 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000024245 cell differentiation Effects 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 102000006573 Chemokine CXCL12 Human genes 0.000 description 4
- 108010008951 Chemokine CXCL12 Proteins 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000009191 jumping Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 3
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000001130 astrocyte Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000012292 cell migration Effects 0.000 description 3
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 210000002536 stromal cell Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 208000020431 spinal cord injury Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 238000012759 hoechst 33342 nuclear staining Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 230000003988 neural development Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000013464 silicone adhesive Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510313256 | 2015-06-09 | ||
CN2015103132562 | 2015-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106237384A CN106237384A (zh) | 2016-12-21 |
CN106237384B true CN106237384B (zh) | 2019-07-05 |
Family
ID=57626810
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510338543.9A Pending CN106279429A (zh) | 2015-06-09 | 2015-06-17 | 与胶原特异结合的基质细胞衍生因子及其应用 |
CN201510671803.4A Active CN106237384B (zh) | 2015-06-09 | 2015-10-16 | 复合梯度浓度生物活性因子组织支架、其制备方法及应用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510338543.9A Pending CN106279429A (zh) | 2015-06-09 | 2015-06-17 | 与胶原特异结合的基质细胞衍生因子及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN106279429A (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11213613B2 (en) | 2015-06-12 | 2022-01-04 | Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences | Three-dimensional tissue scaffold with stem cell attracting element and use thereof |
CN109081872A (zh) * | 2017-06-13 | 2018-12-25 | 中国科学院遗传与发育生物学研究所 | 一种诱导鼓膜再生的功能胶原生物材料及其制备方法 |
CN109224128B (zh) * | 2017-07-11 | 2021-04-30 | 中国科学院苏州纳米技术与纳米仿生研究所 | 负载生物活性因子的胶原支架的缓释体系与其构建方法 |
CN110021354B (zh) * | 2017-07-28 | 2021-06-29 | 深圳华大智造科技股份有限公司 | 用于测序的曝光方法、测序方法及装置和存储介质 |
CN109771699A (zh) * | 2017-11-10 | 2019-05-21 | 中国科学院苏州纳米技术与纳米仿生研究所 | 功能化神经再生胶原支架、其制法及应用 |
CN111840639B (zh) * | 2019-04-24 | 2022-04-19 | 中国科学院苏州纳米技术与纳米仿生研究所 | 胶原/纤维蛋白有序纤维支架及在脊髓损伤修复中的应用 |
CN110129274B (zh) * | 2019-05-17 | 2023-06-02 | 中国科学院苏州纳米技术与纳米仿生研究所 | 含梯度细胞因子的细胞基质材料、其制备方法及应用 |
CN111978406B (zh) * | 2019-05-21 | 2022-06-17 | 中国科学院苏州纳米技术与纳米仿生研究所 | 功能连接多肽、可特异性结合胶原的外泌体载药体系及其应用 |
CN110898254B (zh) * | 2019-12-17 | 2021-11-30 | 浙江大学 | 一种用于修复子宫内膜并提高生育力的生物活性支架 |
CN114533966A (zh) * | 2020-11-26 | 2022-05-27 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种功能化水凝胶支架及其制备方法和应用 |
CN115957379A (zh) * | 2021-10-13 | 2023-04-14 | 北京化工大学 | 一种神经修复膜及其制备方法和应用 |
CN115282341B (zh) * | 2022-06-27 | 2023-05-23 | 华南理工大学 | 一种具有多肽双向梯度分布表面的多孔金属材料及其制备方法与应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1453354A (zh) * | 2003-05-19 | 2003-11-05 | 浙江大学 | 在聚合物生物材料表面引入细胞生长因子的方法 |
CN1807458A (zh) * | 2005-12-26 | 2006-07-26 | 烟台正海生物技术有限公司 | 活化的胶原骨修复材料及其专用融合活性骨修复因子 |
CN101507835A (zh) * | 2009-03-10 | 2009-08-19 | 广州迈普再生医学科技有限公司 | 一种纳米仿生创面覆盖物及其制备方法 |
CN101692986A (zh) * | 2009-03-10 | 2010-04-14 | 广州迈普再生医学科技有限公司 | 一种具有生物活性的人工硬脑膜及其制备方法 |
CN102198291A (zh) * | 2011-05-16 | 2011-09-28 | 暨南大学 | 一种具有连续梯度性能的多糖基神经修复支架材料及其制备方法 |
CN102977391A (zh) * | 2012-12-03 | 2013-03-20 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种在组织工程支架上定量装载生长因子的方法及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101280001B (zh) * | 2007-04-02 | 2012-06-13 | 再生医药有限公司 | 人SDF-1α的制备及由此获得的人SDF-1α及其用途 |
-
2015
- 2015-06-17 CN CN201510338543.9A patent/CN106279429A/zh active Pending
- 2015-10-16 CN CN201510671803.4A patent/CN106237384B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1453354A (zh) * | 2003-05-19 | 2003-11-05 | 浙江大学 | 在聚合物生物材料表面引入细胞生长因子的方法 |
CN1807458A (zh) * | 2005-12-26 | 2006-07-26 | 烟台正海生物技术有限公司 | 活化的胶原骨修复材料及其专用融合活性骨修复因子 |
CN101507835A (zh) * | 2009-03-10 | 2009-08-19 | 广州迈普再生医学科技有限公司 | 一种纳米仿生创面覆盖物及其制备方法 |
CN101692986A (zh) * | 2009-03-10 | 2010-04-14 | 广州迈普再生医学科技有限公司 | 一种具有生物活性的人工硬脑膜及其制备方法 |
CN102198291A (zh) * | 2011-05-16 | 2011-09-28 | 暨南大学 | 一种具有连续梯度性能的多糖基神经修复支架材料及其制备方法 |
CN102977391A (zh) * | 2012-12-03 | 2013-03-20 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种在组织工程支架上定量装载生长因子的方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106279429A (zh) | 2017-01-04 |
CN106237384A (zh) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106237384B (zh) | 复合梯度浓度生物活性因子组织支架、其制备方法及应用 | |
Weir et al. | Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking | |
Manchineella et al. | Surface-functionalized silk fibroin films as a platform to guide neuron-like differentiation of human mesenchymal stem cells | |
Lin et al. | The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds | |
Risau | Developing brain produces an angiogenesis factor. | |
Gospodarowicz et al. | Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. | |
Berns et al. | Aligned neurite outgrowth and directed cell migration in self-assembled monodomain gels | |
Lanfer et al. | The growth and differentiation of mesenchymal stem and progenitor cells cultured on aligned collagen matrices | |
Choi et al. | Cell behavior on extracellular matrix mimic materials based on mussel adhesive protein fused with functional peptides | |
Zangi et al. | High-yield isolation, expansion, and differentiation of rat bone marrow–derived mesenchymal stem cells with fibrin microbeads | |
WO2008150101A2 (en) | Chimeric polypeptide including a mussel adheisve protein and extracellular matrix | |
Yuan et al. | Reciprocal interaction between vascular niche and sweat gland promotes sweat gland regeneration | |
JP2008501724A (ja) | 組織材料およびマトリックス | |
Zhu et al. | Bioorthogonal DOPA-NGF activated tissue engineering microunits for recovery from traumatic brain injury by microenvironment regulation | |
Revkova et al. | Spidroin silk fibers with bioactive motifs of extracellular proteins for neural tissue engineering | |
Schütze et al. | Expression, purification, and functional testing of recombinant CYR61/CCN1 | |
JP7071270B2 (ja) | 統合細胞 | |
Silva et al. | Fibrin functionalization with synthetic adhesive ligands interacting with α6β1 integrin receptor enhance neurite outgrowth of embryonic stem cell-derived neural stem/progenitors | |
Hameed et al. | An overview of bio-actuation in collagen hydrogels: a mechanobiological phenomenon | |
CN111936560B (zh) | 用于刺激神经再生、骨生成和血管生成的水凝胶 | |
Edwards et al. | Differentiation of adipose derived stem cells to keratinocyte-like cells on an advanced collagen wound matrix | |
Zhang et al. | Compatibility of neural stem cells with functionalized self-assembling peptide scaffold in vitro | |
Zhou et al. | Promotion of adhesion and proliferation of endothelial progenitor cells on decellularized valves by covalent incorporation of RGD peptide and VEGF | |
Kalter et al. | Receptors for Transforming Growth Factor-S (lGF-{j) on Rat Lung Fibroblasts Have Higher Affinity for IDF-, 81 than for IDF-{j2 | |
CN111840639B (zh) | 胶原/纤维蛋白有序纤维支架及在脊髓损伤修复中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220129 Address after: 100000 b-1608-029, 16th floor, building 1, No. 18, Zhongguancun East Road, Haidian District, Beijing Patentee after: BEIJING TONGJIAN REGENERATION MEDICAL TECHNOLOGY Co.,Ltd. Address before: 215123, Suzhou, Jiangsu province Suzhou Industrial Park alone villa lake high Parish, if the waterway 398 Patentee before: SUZHOU INSTITUTE OF NANO-TECH AND NANO-BIONICS (SINANO), CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220401 Address after: No.99, Chuqiao Road, New District, Zhenjiang City, Jiangsu Province, 212000 Patentee after: Jiangsu dubu Biotechnology Co.,Ltd. Address before: 100000 b-1608-029, 16th floor, building 1, No. 18, Zhongguancun East Road, Haidian District, Beijing Patentee before: BEIJING TONGJIAN REGENERATION MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161221 Assignee: Dubu Wuqi Biomedical Technology (Jiangsu) Co.,Ltd. Assignor: Jiangsu dubu Biotechnology Co.,Ltd. Contract record no.: X2023980035226 Denomination of invention: Composite gradient concentration bioactive factor tissue scaffold, its preparation method and application Granted publication date: 20190705 License type: Exclusive License Record date: 20230504 |
|
EE01 | Entry into force of recordation of patent licensing contract |